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Abstract: Sources of health disparities such as educational attainment, cardiovascular risk factors,
and access to health care affect cognitive impairment among older adults. To examine the extent to
which these counteracting changes affect cognitive aging over time among Mexican older adults,
we examine how sociodemographic factors, cardiovascular diseases, and their treatment relate to
changes in cognitive function of Mexican adults aged 60 and older between 2001 and 2015. Self
and proxy respondents were classified as dementia, cognitive impairment no dementia (CIND),
and normal cognition. We use logistic regression models to examine the trends in dementia and
CIND for men and women aged 60 years or older using pooled national samples of 6822 individuals
in 2001 and 10,219 in 2015, and sociodemographic and health variables as covariates. We found
higher likelihood of dementia and a lower risk of CIND in 2015 compared to 2001. These results
remain after adjusting for sociodemographic factors, cardiovascular diseases, and their treatment.
The improvements in educational attainment, treatment of diabetes and hypertension, and better
access to health care in 2015 compared to 2001 may not have been enough to counteract the combined
effects of aging, rural residence disadvantage, and higher risks of cardiovascular disease among older
Mexican adults.
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1. Introduction
Over the past 15 years, research on cognitive impairment and dementia in low- and
middle-income countries has increased as the potential for a significant increase in dementia burden in faster-aging populations occurs [1]. Data from the Mexican Health and
Aging Study (MHAS), a nationally representative panel study, has been widely used by
researchers interested in cognitive aging. Several studies [2,3] have found that older age,
fewer years of education, female sex, and rural residence are strong sociodemographic predictors of cognitive impairment. Highly prevalent chronic diseases among Mexican adults,
such as hypertension, stroke, and diabetes, are associated with cognitive impairment [4,5].
In Mexico, it is well established that more recent cohorts of older adults aged 60 and
older have higher educational achievement [6]. However, as a group, the more recent
cohorts also have a higher prevalence of obesity, diabetes, hypertension, and physical
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disability [7,8]. This combination of change in key socioeconomic factors and health risks
of the older adult population is quite evident by comparing cohorts who are only ten years
apart, for example, those 60 and older in 2001 and 2012 [9–11]. Over the same decade, the
country implemented reforms in social protection programs that benefit older adults, most
notably the gradual implementation of Seguro Popular, a public health insurance program
seeking to achieve universal health care, which started circa 2003 [12]. Previous work
reports noticeable gains in the share of older adults with health insurance [13], the use of
preventive care tests [4], and improved awareness and treatment of chronic conditions
such as hypertension and diabetes [10]. Gender-specific associations have shown that the
availability of health insurance is more likely to increase medical service utilization in
women than in men [14].
This combination of relatively fast changes in sociodemographic and population health
profiles of older adults likely contributed to changes in the burden of cognitive impairment
and dementia. In high-income countries, despite increasing trends in cardiovascular
health, previous studies report a decline in dementia incidence or prevalence among older
adults, which they attribute largely to improvements in treatments of cardiovascular risk
factors and rising levels of education [15–17]. In Mexico, it is unclear how the important
sociodemographic and health-related changes previously mentioned, which occurred
mostly in the last two decades [18], are associated with changes in cognitive aging among
older adults. We seek to fill this gap by comparing data from MHAS collected at two
different points in time: 2001 and 2015.
The aim of this manuscript was to examine how sociodemographic factors, cardiovascular diseases, and their treatment relate to the cognitive status of Mexican adults aged 60
and older between 2001 and 2015. We hypothesized that higher educational achievement
and more access to health care, including treatment of cardiovascular diseases, would
imply a trend towards better cognitive function. On the other hand, survival to older
ages and a higher prevalence of chronic diseases among survivors would indicate a trend
towards worse cognitive function. These counter-acting influences mean that the overall
time trend in cognitive function is ambiguous. Our approach sought to inform the extent
to which the future burden of cognitive aging in Mexico can be potentially addressed with
health interventions targeting better prevention, management, and treatment of highly
prevalent chronic conditions.
2. Materials and Methods
2.1. Participants
The MHAS is a longitudinal cohort study of adults aged 50 and older in Mexico with
national and urban-rural representation. The first wave was in 2001 with a sample of adults
born in 1951 or earlier. Four follow-up waves were in 2003, 2012, 2015, and 2018 [19]. The
study follows participants until their death. Additional refresher cohorts include those born
in 1952–1961, added in 2012, and those born in 1962–1968, added in 2018. We used data
from the 2001 and 2015 years for the current study [20]. The MHAS study seeks to complete
interviews directly with the participants, but interviews by proxy are possible in cases of
extreme disability, illness, or temporary absence. Figure 1 illustrates the sample selection
process in both waves for the current analyses. We included all participants aged 60 and
over who answered the survey through a direct or proxy interview. We selected individuals
who completed at least two of five cognitive tasks included in the MHAS cognitive battery
from those with a direct interview. Participants who refused the full cognitive assessment
and those who completed only one task were excluded from our analysis (n = 334 in 2001
and n = 86 in 2015). The excluded participants tend to be male, older, and less educated.
From proxy participants, we excluded those with incomplete information (n = 2 in 2001
and n = 2 in 2015). The final sample was 6822 participants in 2001 and 10,219 in 2015, which
we treat as two cross-sections for our comparison. Individuals present in both cohorts were
2951, while 3871 were included only in 2001 and 8268 only in 2015.
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Underlying the process of cognitive aging are life-course socioeconomic and health
conditions, current health conditions (cerebrovascular conditions, health behaviors, and
health care), and genetic factors associated with normal or pathological (neurodegenerative disease) brain changes during aging [22]. Brain and cognitive reserve are key
concepts to capture potential differences in the brain’s structural aspects and compensatory
mechanisms that shape how the brain copes with age-related changes and pathology
such as dementia [23]. These concepts include characteristics such as anatomical features of the brain structure, and the brain function indicators such as educational and
occupational attainment.
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2.3. Cognitive Measures
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For respondents represented by a proxy, cognitive function was assessed through
the brief version of the IQCODE [27], a 16-item questionnaire on cognitive decline in the
elderly, rated on a 5-point scale from 1 “much improved” to 5 “much worse.” An informant
who knew about the participant’s daily functioning, usually a spouse or adult child or
caregiver, rated the participant’s cognitive status compared to how it was two years earlier.
We used a cut-point of 3.4 and above to classify dementia, as the scale has a reported
sensitivity of 85% and a specificity of 80% in population-based cohorts [30].
2.4. Covariates
Following previous research [3,8,18,26,31,32], we included the following covariates
shown to have an association with cognitive impairment. Sociodemographic variables:
sex (male/female); age used as a continuous or categorical variable (60 to 74 years and
≥75 years); years of formal education as a continuous or categorical variable (0 years,
1 to 6 years, and ≥7 years) following the formative periods in the Mexican education system; and area of residence as a categorical variable (rural for ≤2500 people and urban
>2500 people). Cardiovascular risk factors: Self-reported stroke, diabetes, heart disease,
and hypertension (all yes/no). Cardiovascular treatment: Among those who have each
condition, self-reported use of medications for stroke, diabetes (either oral medications
or insulin), heart disease, and hypertension (all yes/no). Body mass index (BMI); calculated with self-reported weight [kilograms] divided by height [meters and centimeters]
squared [kilogram per square meter] categorized as underweight (<18.5), normal (18.5–
24.9), overweight (25.0–29.9), obese (≥30) based on the World Health Organization (WHO)
classification. Health insurance: Self-reported dichotomous variable (yes-no).
2.5. Statistical Analysis
For descriptive analyses, we examined differences in covariates between total participants in the 2001 and 2015 cohorts and stratified by cognitive status using a t-test or
χ2 test as appropriate. Because education is a critical covariate of cognitive aging, and
there are important gender differences in educational achievement in Mexico, we present
the multivariate results for the total analytical sample and results stratified by sex. For
multivariable analyses, we pooled data from both years (2001 and 2015) and estimated two
logistic regression models. The first model included the dichotomous dependent variable
indicating if an individual had dementia versus no dementia (normal cognition and CIND);
in the second model, CIND versus normal cognition was the dependent variable. In each
model, we included a linear trend variable with the value 0 in 2001 and 1 in 2015. An
odds ratio less or greater than 1 in the trend variable would indicate a decrease or an
increase, respectively, in the likelihood of dementia and CIND in 2015 compared to 2001.
We estimated an unadjusted model with the trend variable only and a fully adjusted model
including all covariates: sociodemographic factors, BMI, each of four cardiovascular diseases, treatment for each disease, and health insurance. We tested for interactions between
each independent variable and the trend variable to assess if the effect of each covariate
was different in 2015 compared to 2001. We used IBM SPSS Statistics, Version 25.0 (IBM
Corp., Armonk, NY, USA) for statistical analyses.
3. Results
3.1. Trends in Cognitive Status
Roughly 70–80% of the sample was classified as normal cognition (70.6% in 2001
and 79.1% in 2015). CIND individuals represented 23.3% (95% Confidence Interval [CI],
22.2–24.4) of the sample in 2001 and 13.5% (95% CI, 12.8–14.3) in 2015 (p < 0.001). Those
classified with dementia were 6.1% (95% CI, 5.5–6.7) in 2001 and 7.3% (95% CI, 6.8–7.9) in
the 2015 sample (p = 0.002). Table S1 in the Supplementary Material shows the distribution
of covariates by cognition status for both years.
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3.2. Trends in Sociodemographic Characteristics
Table 1 shows descriptive characteristics of Mexican adults aged 60 and older in the
years 2001 and 2015. Results were weighted to represent the national populations of older
adults in the corresponding year. Compared with 2001, the cohort for 2015 contained a
significantly larger proportion of individuals aged 75 years and older and this cohort had a
higher average age. The share of women increased from 52.4% in 2001 to 54.8% in 2015
(p = 0.002). On average, older adults in 2015 had one more year of education compared
to those in 2001 (p < 0.001). The proportion of individuals with no schooling decreased
from 36.0% in 2001 to 24.0% in 2015 (p < 0.001), and the share of participants with seven
or more years of education increased from 13.7% in 2001 to 22.9% in 2015 (p < 0.001). The
absolute increase in educational achievement years was larger for men than for women
and larger for those aged 60–74 compared to those aged 75 and older (data not shown). The
proportion of individuals living in rural or urban areas did not differ significantly between
2001 and 2015.
Table 1. Characteristics of participants aged 60 and older of the 2001 and 2015 cohorts a .

Age, y
60–74 years
≥75 years
Mean (SD)
Sex
Male
Female
Education, y
No schooling
1–6 years
≥7 years
Mean (SD)
Residence
Urban
Rural
Cardiovascular conditions
Hypertension
Diabetes
Heart attack
Stroke
CVD Treatment b
Hypertension
Diabetes
Heart attack
Stroke
BMI
18.5–24.9 (Normal)
<18.5 (Underweight)
25.0–29.9 (Overweight)
≥30 (Obese)
Health insurance (yes)

2001

2015

n = 6822

n = 10219

p Value

5224 (74.5)
1598 (25.5)
69.3 (7.5)

7073 (72.5)
3146 (27.5)
71.2 (7.9)

<0.001
<0.001
<0.001

3169 (47.6)
3653 (52.4)

4496 (45.2)
5723 (54.8)

0.002

2138 (36.0)
3646 (50.3)
1038 (13.7)
3.6 (3.9)

2142 (24.0)
5541 (52.9)
2536 (22.9)
4.9 (4.5)

<0.001
0.31
<0.001
<0.001

4936 (57.8)
1886 (42.2)

7267 (60.5)
2952 (39.5)

0.08

2876 (41.3)
1188 (16.8)
298 (3.3)
254 (3.5)

5354 (50.3)
2686 (24.9)
477 (3.8)
293 (2.6)

<0.001
<0.001
0.37
0.002

2190 (76.3)
1030 (87.6)
211 (66.8)
141 (53.4)

4738 (85.9)
2499 (93.2)
341 (70.7)
153 (46.9)

<0.001
<0.001
0.95
0.44

2491 (38.7)
158 (3.5)
2983 (41.5)
1183 (16.3)
4287 (56.9)

3511 (34.8)
185 (2.2)
4331 (42.9)
2182 (20.1)
9376 (90.4)

0.004
0.03
0.08
<0.001
<0.001

Notes: Characteristics are presented as n (%) unless otherwise indicated. Values in parenthesis are weighted %
derived using sampling weights of the MHAS. a The reported p value is for χ2 or t test for a significant difference
in proportion or mean between years. b Cardiovascular treatment for those with each condition. Abbreviations:
BMI, body mass index; CVD, cardiovascular conditions; SD, standard deviation.

3.3. Trends in Cardiovascular Risks and Treatment
The prevalence of some, but not all, cardiovascular conditions among Mexican adults
aged 60 or older was higher in 2015 compared to 2001. Diabetes increased from 16.8% to
24.9% (p < 0.001). Similarly, hypertension increased from 41.3% in 2001 to 50.3% in 2015
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(p < 0.001). Conversely, the prevalence of stroke decreased from 3.5% in 2001 to 2.6% in
2015 (p = 0.002), whereas heart disease prevalence did not change significantly. Regarding
treatment among older adults, the proportion of participants with hypertension treatment
increased from 76.3% in 2001 to 85.9% in 2015 (p < 0.001). Similarly, diabetes treatment
increased from 87.6% to 93.2% (p < 0.001). Heart attack and stroke treatment were similar
in the two periods.
Based on BMI classification, the share of individuals in the normal range decreased
from 38.7% in 2001 to 34.8% (p = 0.004) in 2015. The underweight percentage also decreased
slightly, from 3.5% to 2.2% (p = 0.03). The fraction of overweight remained the same
between the two periods, while obesity increased from 16.3% in 2001 to 20.1% in 2015
(p < 0.001). Compared with 2001, the proportion of individuals with health insurance
increased significantly, from 56.9% to 90.4% in 2015 (p < 0.001).
3.4. Regression Results
Table 2 shows the results of a fully adjusted logistic regression model, for the overall
sample and stratified by sex, with dementia (versus normal cognition or CIND) as the
outcome variable, and using pooled 2001 and 2015 data. The trend variable in the first row
of the table represents the adjusted odds ratio (OR) of dementia in 2015 compared with
2001. The unadjusted OR of the trend variable (results not shown) showed a significantly
higher likelihood of dementia in 2015 compared to 2001 for the overall sample (OR [95%
confidence interval]: (1.23 [1.08–1.39], p = 0.001) and for men (1.37 [1.12–1.69], p = 0.002),
but not significantly so for women (1.13 [0.97–1.32], p = 0.118)). After controlling for the
effect of sociodemographic factors, cardiovascular conditions, treatment of cardiovascular
conditions, BMI, and health insurance, both the overall sample and males continued to
show higher odds of dementia in 2015. For females, the odds of dementia were also higher,
now reaching statistical significance.
Table 2. Odds ratios for dementia, overall and stratified by sex a .
Overall

Trend (2015 vs. 2001)
Sex, Female
Age, y
60–74 years
≥75 years
Education, y
0 years
1–6 years
≥7 years
Residence
Urban
Rural
Cardiovascular disease
Hypertension
Diabetes
Heart disease
Stroke
BMI
Underweight (<18.5)
Normal (18.5–24.9)
Overweight (25.0–29.9)
Obese (≥30.0)

Males

Females

OR (95% CI)

p Value

OR (95% CI)

p Value

OR (95% CI)

p Value

1.27 (1.10–1.47)
1.50 (1.32–1.72)

0.001
<0.001

1.33 (1.09–1.69)
NA

0.020

1.24 (1.03–1.49)
NA

0.020

1 [Reference]
4.53 (3.97–5.17)

<0.001

1 [Reference]
4.72 (3.78–5.90)

1.93 (1.56–2.40)
1.36 (1.11–1.66)
1 [Reference]

<0.001
0.003

2.13 (1.49–3.05)
1.40 (1.00–1.95)
1 [Reference]

<0.001
<0.001
0.05

1 [Reference]
4.34 (3.68–5.13)
1.81 (1.38–2.37)
1.32 (1.02–1.70)
1 [Reference]

<0.001
<0.001
0.03

1 [Reference]
1.04 (0.90–1.20)

0.57

1 [Reference]
1.36 (1.09–1.71)

0.006

1 [Reference]
0.87 (0.72–1.05)

0.16

1.27 (1.00–1.61)
1.60 (1.08–2.36)
1.46 (0.94–2.27)
2.18 (1.52–3.13)

0.05
0.02
0.09
<0.001

0.74 (0.46–1.20)
1.56 (0.82–2.98)
1.46 (0.76–2.81)
3.80 (2.21–6.54)

0.23
0.17
0.25
<0.001

1.55 (1.17–2.05)
1.68 (1.02–2.77)
1.46 (0.79–2.68)
1.55 (0.95–2.51)

0.002
0.04
0.22
0.08

1.46 (1.06–2.01)
1 [Reference]
0.72 (0.63–0.83)
0.63 (0.52–0.77)

0.02

1.68 (1.01–2.79)
1 [Reference]
0.70 (0.55–0.88)
0.55 (0.38–0.82)

0.04

1.36 (0.90–2.07)
1 [Reference]
0.73 (0.61–0.88)
0.66 (0.52–0.83)

0.14

<0.001
<0.001

0.002
0.003

0.001
0.001
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Table 2. Cont.
Overall

Males

Females

OR (95% CI)

p Value

OR (95% CI)

p Value

OR (95% CI)

p Value

0.83 (0.65–1.06)
0.91 (0.60–1.36)
0.99 (0.59–1.68)
3.24 (2.08–5.05)
0.75 (0.63–0.89)

0.15
0.65
0.98
<0.001
0.001

1.33 (0.81–2.19)
1.10 (0.56–2.14)
1.08 (0.51–2.32)
2.13 (1.11–4.09)
0.94 (0.71–1.26)

0.25
0.77
0.82
0.022
0.72

0.71 (0.54–0.94)
0.80 (0.48–1.34)
0.93 (0.45–1.92)
4.04 (2.18–7.46)
0.66 (0.54–0.82)

0.02
0.41
0.86
<0.001
<0.001

b

CVD Treatment
Hypertension
Diabetes
Heart disease
Stroke
Health care insurance c

Note. a Adjusted odds ratios were derived using logistic regression models with pooled data from 2001 (n = 6791) and 2015 (n = 10,215) for
the overall sample; 2001 (n = 3155) and 2015 (n = 4494) for males; 2001 (n = 3636) and 2015 (n = 5271) for females. The dependent variable
was dementia compared to normal cognition or CIND. b Cardiovascular treatment for those with each condition. c Health care insurance
for those with insurance. Abbreviations: OR = odds ratio; CI = confidence interval; BMI = Body Mass Index; CVD, cardiovascular disease;
NA, not applicable.

For the overall sample, being female (1.50 [1.32–1.72], p < 0.001), being 75 years
or older (4.53 [3.97–5.17], p < 0.001), and low educational achievement were associated
with a significantly higher odds of dementia. Compared to having seven or more years
of education, individuals with no schooling (1.93 [1.56–2.40], p < 0.001) and those with
one to six years of education (1.36 [1.11–1.66], p = 0.003) had a higher likelihood of dementia. Higher odds of dementia also were associated with a history of hypertension,
diabetes, and stroke. Being overweight (0.72 [0.63–0.83], p < 0.001) or obese (0.63 [0.52–0.77],
p < 0.001) was associated with lower odds of dementia compared to having normal BMI.
The results showed noticeable differences when stratified by sex. Older age and lower
education were associated with higher odds of dementia for both males and females. Living
in rural areas was associated with increased odds of dementia in males (1.36 [1.09–1.71],
p = 0.006) but not in females. Odds were significantly increased for those with hypertension
(1.55 [1.17–2.05], p = 0.002) and diabetes (1.68 [1.02–2.77], p = 0.04) in females but not in
males, while stroke was significant only in males (3.80 [2.21–6.4], p < 0.001). Similar to
the overall sample results, being overweight or obese was associated with lower odds of
dementia in males and females compared to those with normal BMI.
Regarding self-reported treatment, the effect of diabetes and heart attack treatment
was not significant, although both were associated with lower odds of dementia; for
hypertension treatment, the association was significant only in females (0.71 [0.54–0.94],
p = 0.02) but not in males. Receiving treatment for stroke was associated with a significantly higher odds of dementia, in both males (2.13 [1.11–4.09], p = 0.02) and females
(4.04 [2.18–7.46], p < 0.001). Having health care insurance was associated with lower odds
of dementia in females (0.66 [0.54–0.82], p < 0.001) but not in males.
We tested for an interaction effect between each covariate and the trend variable
(results not shown), controlling for the main effects of all the other covariates. Hypertension
treatment was associated with significantly lower odds of dementia in 2015 (0.51 [0.29–0.90],
p = 0.02) compared with 2001 in females, but not in males. No other interactions with the
trend variable were significant.
Table 3 shows the results of a logistic regression model for the overall sample and stratified by sex with CIND (versus normal cognition) as the outcome variable, using pooled 2001
and 2015 data. The unadjusted OR of the trend variable (results not shown) showed a significant decline in the likelihood of CIND between 2001 and 2015 for the overall sample (OR
[95% CI]: (0.52 [0.48–0.56],
p < 0.001),
for men (0.62 [0.55–0.69],
p < 0.001), and for women (0.43 [0.38–0.49], p < 0.001)). After controlling for all covariates,
these effects of the trend variable remained the same.
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Table 3. Odds ratios for CIND, overall and stratified by sex a .
Overall

Trend (2015 vs. 2001)
Sex, Male
Age, y
60–74 years
≥75 years
Education, y
0 years
1–6 years
≥7 years
Residence
Urban
Rural
Cardiovascular disease
Hypertension
Diabetes
Heart disease
Stroke
BMI
Underweight (<18.5)
Normal (18.5–24.9)
Overweight (25.0–29.9)
Obese (≥30.0)
CVD Treatment b
Hypertension
Diabetes
Heart disease
Stroke
Health care insurance c

Males

Females

OR (95% CI)

p Value

OR (95% CI)

p Value

OR (95% CI)

p Value

0.53 (0.49–0.58)
1.33 (1.22–1.44)

<0.001
<0.001

0.61 (0.54–0.69)
NA

<0.001

0.46 (0.41–0.53)
NA

<0.001

1 [Reference]
1.01 (0.92–1.12)

0.70

1 [Reference]
1.26 (1.11–1.44)

0.83 (0.72–0.94)
0.95 (0.85–1.06)
1 [Reference]

0.006
0.38

0.76 (0.63–0.91)
1.00 (0.86–1.16)
1 [Reference]

<0.001
0.004
0.97

1 [Reference]
0.78 (0.68–0.91)
0.89 (0.74–1.07)
0.90 (0.77–1.06)
1 [Reference]

0.001
0.23
0.22

1 [Reference]
1.36 (1.23–1.49)

<0.001

1 [Reference]
1.36 (1.19–1.54)

<0.001

1 [Reference]
1.36 (1.18–1.56)

<0.001

0.98 (0.83–1.14)
1.10 (0.83–1.46)
0.69 (0.46–1.05)
0.71 (0.48–1.06)

0.80
0.50
0.09
0.09

0.95 (0.76–1.19)
1.20 (0.82–1.75)
0.78 (0.47–1.29)
0.61 (0.32–1.14)

0.68
0.33
0.34
0.12

0.98 (0.78–1.22)
0.98 (0.63–1.52)
0.53 (0.25–1.11)
0.80 (0.48–1.33)

0.86
0.93
0.09
0.40

1.05 (0.79–1.40)
1 [Reference]
0.88 (0.80–0.96)
0.70 (0.62–0.79)

0.72

0.39
0.07
0.002

0.94 (0.62–1.42)
1 [Reference]
0.86 (0.75–0.98)
0.67 (0.56–0.79)

0.77

0.008
<0.001

1.19 (0.79–1.78)
1 [Reference]
0.89 (0.78–1.01)
0.75 (0.62–0.90)

0.03
<0.001

0.97 (0.83–1.14)
0.98 (0.73–1.32)
1.18 (0.73–1.92)
1.56 (0.92–2.64)
0.85 (0.77–0.95)

0.77
0.91
0.48
0.09
0.004

1.02 (0.80–1.29)
0.92 (0.62–1.37)
1.06 (0.58–1.92)
1.93 (0.90–4.11)
0.87 (0.75–1.01)

0.84
0.70
0.84
0.08
0.07

0.95 (0.76–1.19)
1.07 (0.68–1.70)
1.49 (0.64–3.45)
1.30 (0.60–2.83)
0.82 (0.70–0.95)

0.70
0.74
0.35
0.50
0.01

Notes: a Adjusted odds ratios were derived using logistic regression models with pooled data from 2001 (n = 6382) and 2015 (n = 9464) for
the overall sample; 2001 (n = 3012) and 2015 (n = 4214) for males; 2001 (n = 3370) and 2015 (n = 5250) for females. The dependent variable
was CIND compared to normal cognition. b Cardiovascular treatment for those with each condition. c Health care insurance for those with
insurance. Abbreviations: CIND = cognitive impairment no dementia; OR = odds ratio; CI = confidence interval; BMI = Body Mass Index.
CVD, cardiovascular disease; NA, not applicable.

For the overall sample, the fully adjusted model showed that being male
(1.33 [1.22–1.44], p < 0.001) and living in rural areas (1.36 [1.23–1.49], p < 0.001) were associated with higher odds of CIND. Having no formal schooling (0.83 [0.72–0.94], p = 0.006),
being overweight (0.88 [0.80–0.96], p = 0.008) or obese (0.70 [0.62–0.79], p < 0.001), and
having access to health care (0.85 [0.77–0.95], p = 0.004) were all associated with lower odds
of CIND. The results stratified by sex showed noticeable differences. For males, the odds of
CIND were higher in those aged 75 years and older (1.26 [1.11–1.44], p < 0.001), while for
females, the odds of CIND were lower in the same age group (0.78 [0.68–0.91], p < 0.001).
Having no formal schooling was significantly associated with lower odds of CIND in males
(0.76 [0.63–0.91], p = 0.004) but not in females. Having health care insurance was associated
with lower odds of CIND in females (0.82 [0.70–0.95], p = 0.01) but not in males. Other
results were similar for men and women; the odds of CIND were significantly higher for
rural residence in males (1.36 [1.19–1.54], p < 0.001) and females (1.36 [1.18–1.56], p < 0.001).
Compared to those with normal weight, the odds of CIND were lower for obesity in males
(0.75 [0.62–0.90], p = 0.002) and females (0.67 [0.56–0.79], p < 0.001). Of note, there were no
significant effects (p > 0.05) on the odds of CIND associated with any of the cardiovascular
health conditions or the treatment of these conditions for the overall sample or for the
sample stratified by sex.
We tested for an interaction effect between each covariate and the trend variable,
controlling for the main effects of all the other covariates. We found significant interactions
with the sociodemographic variables (sex, age, education, rural residence), implying that
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the effect of these variables on CIND was higher in 2015 compared to their effect in 2001.
No other interactions were significant.
4. Discussion
Our data confirmed three important changes that occurred during the 14-year period
that may have affected the burden of cognitive aging. The composition of older Mexican
adults changed towards their being older and more educated, although a gender gap
in education favoring men was still evident. Other major changes were a much higher
level of health insurance coverage and a higher prevalence of chronic health conditions,
all consistent with previous research [18,32,33]. Because of these changes, it is possible
that participants in 2015 were more aware of cardiovascular conditions than participants
in 2001.
With this context of sociodemographic, health conditions, and health care changes,
we used the cognitive status classification to examine whether the likelihood of cognitive
impairment was different in 2015 compared to 2001 among adults aged 60 and older
stratified by sex, and the effect of these covariates. Our multivariate models showed
a robust result of higher odds of dementia and lower odds of CIND for both men and
women in 2015 compared to 2001. Factors associated with a higher likelihood of dementia,
such as older age, some cardiovascular risks, and rural residence, were operating in both
years. Other factors associated with lower odds of dementia counteracted, such as higher
educational achievement, being overweight and obese, and having health insurance. After
all these factors were taken into account, a higher likelihood of dementia remained in 2015
for both men and women. Further, our results showed that the effect of these factors on the
likelihood of dementia was overall similar for both years.
Our results for dementia stratified by sex also convey noteworthy differences regarding the covariates. The detrimental effects of rural residence and stroke history were
significant only for men, while the effects of hypertension and diabetes were evident only
for women. The beneficial influence of health insurance was significant for women but
not for men, a finding which was consistent with previous literature [14]. This finding is
also consistent with our result that hypertension treatment was higher only for women,
and the effect appeared to be higher in 2015 compared to 2001. This set of results points to
future research regarding gender disparities in the disease risks associated with dementia
in Mexican men and women.
Surprisingly, stroke treatment showed a significant association with higher odds of
dementia in both males and females. Further analyses showed that the time following
stroke was shorter (five years or less) among those with cognitive impairment who were
using medication compared to those with no treatment, suggesting a higher rate of poststroke complications [34].
The covariates for the likelihood of CIND were quite different from those for dementia:
only sociodemographic factors such as rural residence and obesity were associated with
higher likelihood of CIND, and none of the cardiovascular risks or their treatment showed
significant effects. The beneficial role of health insurance was evident only for women,
and that of more education only for men. Overall, our CIND results seem rather unstable,
consistent also with previous research [35]; CIND is an intermediate or transition stage
between normal cognition and dementia. Previous studies using population-based data
have reported that CIND is affected by myriad factors [36], and its measurement is a
recognized challenge [37]. The MHAS made changes to the cognitive assessment over time,
which could potentially influence the assessment of CIND. To minimize the impact of these
changes, though, we classified cognitive status using the five original cognitive domains
from 2001 that were also included in 2015. Future research ought to use longitudinal data
to understand better CIND and its measurement.
Our study confirmed an increase in obesity between 2001 and 2015. As in previous
studies [17,38], we found that overweight and obesity were associated with lower odds of
CIND and dementia. This result has been interpreted as evidence of a protective effect of
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higher late-life BMI for dementia as opposed to mid-life obesity [39]. Others have remarked
on the importance of BMI changes during the life cycle to assess this association [40,41].
Rural residence and lack of health insurance are well-established sources of health
disparities in populations worldwide, particularly in low- and middle-income countries [3].
Our results confirm that these are important risk factors for a higher likelihood of both
dementia and CIND. Regarding health insurance, our results showed a beneficial influence
of health insurance in 2015 compared to 2001, particularly among women and among
those aged 75 and older [14]. Future research should further examine the mechanisms
through which the expansion in health insurance over the period could have benefitted
the cognitive function of women more than that of men, including the possibility of better
treatment and awareness of diseases among women [10].
Our results with Mexican older adults differ from the results reported by others using
a comparable period in the United States. Using a similar approach, results from the
Health and Retirement Study reported a decrease in the risk of dementia in the United
States between 2000 and 2012 [17]. The authors commented that increasing educational
attainment and better control of cardiovascular risk factors were associated with a lower
risk of dementia over this period. For Mexico, the higher educational attainment we
observed for 2015 was still considerably lower than the gains observed for consecutive
cohorts of older adults in the United States and other developed countries. As Mexico
experienced increasing rates of chronic diseases, a corresponding better control of the
conditions was largely absent. Thus, preventing and treating these diseases represents a
critical opportunity to reduce the prevalence of dementia, in addition to the educational
gains that will continue to prevail in future cohorts entering old age.
We found that being female, older age, no schooling, lack of health insurance coverage,
and cardiovascular risk factors were major contributors to increasing an individual’s odds
of dementia in 2001 and 2015, mirroring what others have reported for other countries [42].
Overall, we interpret our results to indicate that the individual risk of dementia for a person
with a given set of traits—age, sex, education, rural/urban residence, cardiovascular risks,
health insurance—was higher in 2015 than in 2001. Other factors that were not included in
our models may help explain this time trend and could be the subject of future research.
Our study has several limitations. Our cognitive status classification was not based
on clinical diagnoses. The classification of cognitive status for individuals who have data
collected in population surveys depends on the definitions used and the information
captured by the survey instruments. We classified cognitive impairment in self and proxy
respondents using two cognitive screening instruments (CCCE and IQCODE), which
correctly identify individuals with normal cognitive function and dementia [28,43], while
cognitive assessment of those with CIND remains more challenging [37]. Our data also
rely upon self-reported measures to determine if participants have any cardiovascular
conditions. This approach has the limitation that undiagnosed diseases may be present;
the under-reporting of conditions has been described in previous studies [44].
Despite these limitations, we contribute to the conceptual definition of cognitive
status using a population-based survey, with our analyses of national samples of older
adults in Mexico, using the same cognitive assessments, and including direct and proxy
interviews. These efforts represent a significant improvement in our understanding of the
dynamics of cognitive aging in Mexico. Future research using additional MHAS data will
benefit from our work and continue to add to our knowledge of this crucial public health
concern in rapidly aging societies. Policies and programs could focus on the prevention
of cardiovascular diseases and their treatment as a direct strategy to reduce the burden of
cognitive aging in Mexico, particularly among rural populations.
5. Conclusions
Countries like Mexico with a rapidly aging population may not experience quick
increases in dementia prevalence. The trajectory followed will depend on the prevalence of
comorbidities, access to health care, and the treatment and management of such conditions,
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among other factors. Over the 2001 to 2015 period, older age and higher prevalence of
cardiovascular risks were evident, concurrent with gains in education and health insurance
coverage among older Mexican adults. These risk and beneficial factors likely produced
counteracting effects, leading to a slightly higher risk of dementia by 2015.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/geriatrics6030063/s1, Table S1: Descriptive statistics of MHAS participants aged 60 and over
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Supplementary Table S1.
Summary: Table S1 shows the distribution of sociodemographic variables, cardiovascular
diseases, BMI levels, treatment of cardiovascular conditions and health insurance in those with
normal cognition, CIND, and dementia between 2001 and 2015.
Table S1. Descriptive statistics of MHAS participants aged 60 and over in the 2001 and 2015
cohorts by cognitive status
Normal Cognition

CIND

Dementia

2001

2015

2001

2015

4819 (70.6)

8085 (79.1)

***

1589 (23.3)

1383 (13.5)

***

414 (6.1)

751 (7.3)

Male

2224 (46.2)

3449(42.7)

***

799 (50.3)

767 (55.5)

**

146 (35.3)

280 (37.3)

Female

2595 (53.8)

4636 (57.3)

790 (49.7)

616 (44.5)

268 (64.7)

471 (62.7)

60–74 years

3768 (78.2)

5877 (72.7)

187 (45.2)

233 (31.0)

≥75 years

1051 (21.8)

2208 (27.3)

227 (54.8)

518 (69.0)

68.9 (7.2)

70.2 (7.5)

76.3 (9.5)

79.5 (9.4)

***

No schooling

1535 (31.9)

1551 (19.2)

191 (46.1)

274 (36.5)

**

1-6 years

2573 (53.4)

4407 (54.5)

*

≥7 years

711 (14.8)

2127 (26.3)

***

3.6 (4.0)

5.3 (4.6)

***

Urban

3548 (73.6)

5892 (72.9)

Rural

1271 (26.4)

2193 (27.1)

2043 (42.5)

4254 (52.6)

N

2001

2015
**

Sex

Age, y

Mean (SD)

***

1269(79.9)

963 (69.6)

320 (20.1)

420 (30.4)

***

68.6 (6.8)

71.0 (7.3)

***

412 (25.9)

317 (22.9)

890 (56.0)

753 (54.4)

287 (18.1)

313 (22.6)

3.8 (3.9)

***

***

***

Education, y

Mean (SD)

+

183 (44.2)

381 (50.7)

**

40 (9.7)

96 (12.8)

4.3 (4.2)

***

2.5 (3.4)

3.1 (3.7)

1109 (69.8)

864 (62.5)

***

279 (67.4)

511 (68.0)

480 (30.2)

519 (37.5)

135 (32.6)

240 (32.0)

***

623 (39.3)

672 (48.6)

***

210 (51.2)

428 (57.0)

***

274 (17.3)

349 (25.2)

***

106 (25.8)

216 (28.8)

43 (2.7)

59 (4.3)

31 (7.6)

61 (8.1)

**

Residence

Cardiovascular
diseases
Hypertension
Diabetes

808 (16.8)

2121 (26.2)

Heart disease

224 (4.7)

357 (4.4)

Stroke

152 (3.2)

184 (2.3)

**

46 (2.9)

26 (1.9)

56 (13.6)

83 (11.1)

1693 (35.2)

2613 (32.4)

**

607 (38.2)

542 (39.2)

191 (46.1)

356 (47.4)

96 (2.0)

126 (1.6)

39 (2.5)

27 (2.0)

23 (5.6)

32 (4.3)

2135 (44.3)

3476 (43.0)

697 (43.9)

595 (43.0)

151 (36.5)

260 (34.6)

890 (18.5)

1860 (23.0)

***

244 (15.4)

219 (15.8)

49 (11.8)

103 (13.7)

166 (79.0)

373 (87.1)

94 (88.7)

196 (90.7)

*

+

BMI
Normal
Underweight
Overweight
Obese
CVD Treatmenta
Hypertension

1550 (76.1)

3783 (89.0)

***

474 (76.2)

582 (86.6)

***

Diabetes

697 (86.3)

1982 (93.4)

***

239 (87.2)

321 (92.0)

+

Heart disease

155 (69.8)

256 (71.7)

35 (81.4)

40 (67.8)

21 (67.7)

45 (73.8)

75 (49.3)

81 (44.0)

27 (58.7)

15 (57.7)

39 (69.6)

57 (68.7)

3121 (64.8)

7458 (92.2)

212 (51.2)

681 (90.7)

Stroke
Health insurance

b

***

954 (60.1)

1237(89.4)

***

Notes: CIND, cognitive impairment no dementia; BMI, body mass index; BMI Normal, 18.5-24.9; BMI Underweight, <18.5; BMI
Overweight, 25-29.9; BMI Obese, ≥30; CVD, cardiovascular condition. Characteristics are presented as n (%) unless otherwise
indicated. a Cardiovascular treatment for those with each condition. b Health care insurance for those with insurance.
***p < .001, **p < .01, *p < .05, + p < .10.

**

***

